Filing Details
- Accession Number:
- 0001593968-21-001992
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-18 19:43:27
- Reporting Period:
- 2021-08-17
- Accepted Time:
- 2021-08-18 19:43:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1771917 | Karuna Therapeutics Inc. | KRTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1237564 | M Steven Paul | C/O Karuna Therapeutics, Inc. 99 High Street, 26Th Floor Boston MA 02110 | President &Amp; Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-08-17 | 1,183 | $105.63 | 107,668 | No | 4 | P | Indirect | See footnote (1) |
Common Stock | Acquisiton | 2021-08-18 | 1,181 | $106.10 | 108,849 | No | 4 | P | Indirect | See footnote (1) |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote (1) |
No | 4 | P | Indirect | See footnote (1) |
Footnotes
- The purchases reported on this Form 4 were effected by The Steven M. Paul Revocable Trust.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $105.62 to $105.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (2) and (3) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $105.95 to $106.13, inclusive.